
PERFORMANCE / SINGLE
TESAMORELIN
This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A synthetic GHRH analogue studied for stimulating pulsatile pituitary GH release and downstream IGF-1 elevation.
Available Strengths
- 10MG (TSM10-PEN)
- 20MG (TSM20-PEN)
Research Protocol
Reference titration schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Week 1 | 1 mg | 30 | 0.3 mL |
| Weeks 2+ | 2 mg | 60 | 0.6 mL |
Reconstitution
≈3.33 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 10 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Binds pituitary GHRH receptors, prompting pulsatile growth-hormone secretion studied in lipolysis and protein-synthesis research.
Storage
2–8°C. 2–8°C with bacteriostatic water, use within 7 days; use immediately if prepared with sterile (non-bacteriostatic) water.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source